GO
Loading...

Pfizer Inc

More

  • Where Are The Buying Opportunities? Tuesday, 7 Oct 2008 | 6:59 PM ET

    Which stocks have been unfairly punished over the last three trading days?

  • Fear Factor Vs. Opportunity Knocking Tuesday, 7 Oct 2008 | 4:01 PM ET

    Wall Street struggled with another day of selling as panic seemed to accelerate into the final minutes of trading.

  • Could The Credit Crisis Help Pfizer? Monday, 6 Oct 2008 | 3:46 PM ET

    Pretty much all of biopharma is caught in the downdraft of the markets today with the notable exception of Dendreon (data) and ImClone Systems (a deal).

  • Dendreon, ImClone & Pfizer: Your Emails Friday, 3 Oct 2008 | 10:37 AM ET

    As all eyes remain on Capitol Hill, things remain relatively quiet on the biopharma front. So, it's a good time to go through the Pharma's Market mailbag. The overwhelming majority of emails recently have been about...yeah, you guessed it...Dendreon.

  • Mad Mail: What Happened to China? Thursday, 2 Oct 2008 | 10:17 PM ET

    Plus, should I own Pfizer?

  • Stocks Fall On Bailout Uncertainty Wednesday, 1 Oct 2008 | 5:41 PM ET

    The Dow closed lower on Wednesday as nervous investors found it difficult to muster enthusiasm ahead of the Senate’s vote on a revamped $700 billion rescue plan.

  • The Waiting Game Continues For Lilly & ImClone Monday, 29 Sep 2008 | 10:42 AM ET

    Eli Lilly has been running direct-to-doctor ads over the past few months telling physicians that Effient, the company's new bloodthinner, is "Coming Soon". Well, it may have jumped the gun.

  • Lilly

    Today is the day the FDA is expected to make a decision on the drug. The agency could approve it outright, approve it with conditions/limitations, delay making a decision--again--and order more tests, or reject the pill.

  • S&P Slammed Monday, 22 Sep 2008 | 5:56 PM ET

    The Dow tumbled on Monday as investors worried a $700 billion bailout for the financial sector may not resuscitate a slumping economy...

  • Lightning Round OT: Pfizer, Vale and More Friday, 19 Sep 2008 | 6:51 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • As the press release that came with the book says, "Compact enough to carry in a lab coat pocket, the paperback helps health care practitioners, particularly those who are newcomers to clinical diagnosis, understand and evaluate a wide range of symptoms."

  • Pfizer Is A Driver: "Complaining" Investor Read On! Thursday, 18 Sep 2008 | 4:40 PM ET

    The stock posted its biggest percentage gain in nearly three years and its biggest dollar gain in more than two years, according to CNBC stock-stat maven Robert Hum.

  • Dow Plunges 500 points Monday, 15 Sep 2008 | 4:55 PM ET

    The Dow and S&P 500 fell over 4.5% today, while the Nasdaq composite dropped 3.6%, as concerns over the health of the financial sector intensified following the decision of Lehman Brothers to file for Chapter 11.

  • Pfizer: A Delay And A Deal? Tuesday, 9 Sep 2008 | 12:06 PM ET

    At the risk of getting more emails from conspiracy-theorist readers who think I report too much negative news about Pfizer, here comes another setback for the world's biggest drug company.

  • Cramer makes the call on viewers' favorite stocks.

  • Pharma Stocks

    John Sullivan, the Director of Research at Lerrink Swann, which specializes in healthcare stocks, says there is a potential trading opportunity in the sector related to F & F.

  • Celgene's Success Story Thursday, 4 Sep 2008 | 3:37 PM ET

    One of the biggest biotech success stories is among the companies featured in the afternoon sessions here at the BioCentury/Thomson Reuters investment conference.

  • Medivation's Presentation Thursday, 4 Sep 2008 | 10:18 AM ET
    Medivation

    A little more than 24 hours after announcing its big, lucrative Alzheimer's drug partnership with Pfizer, Medivation had the lead-off position (I wonder if they told organizers they'd be a newsmaker) at today's BioCentury/Thomson Reuters biotech investment conference in New York City.

  • Biotech Bonanza At Industry Conference Thursday, 4 Sep 2008 | 9:09 AM ET

    Today I will be attending and blogging from the 15th Annual Newsmakers in the Biotech Industry conference which is put on by BioCentury Publications and Thomson Reuters. Three dozen biotechs will be making presentations and then doing hour-long q and a's during breakout sessions.

  • Pfizer Finding Innovation At Medivation Wednesday, 3 Sep 2008 | 10:32 AM ET
    Lilly Effient

    In late July at a big scientific conference in Chicago, I reported on new, positive data on Medivation's experimental Alzheimer's drug Dimebon (dim-uh-bahn).